The high expression of PIEZO2 mRNA was correlated to better OS for all NSCLC patients, HR 0.54 (0.42–0.69), P=6.4 x 10-7 (Figure 3C). The gene discussed is PIEZO2; the disease is non-small cell lung carcinoma.